In severe treatment-resistant depression, long-term data show VNS benefits not only persist for 2 years but also continue to emerge in late responders.

ROCKAWAY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology company, today announced that Acacia Clinics and the ...

More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.

For patients with dementia, postoperative delirium can accelerate long-term cognitive decline. Vagus nerve stimulation could reduce brain inflammation and disruptions in awareness and attention.

An implanted device that stimulates the vagus nerve has shown promise for people with long-standing, treatment-resistant ...

Find out how vagus nerve stimulation delivers durable symptom relief and quality of life gains in treatment resistant depression patients.

We’re entering the era of body literacy.

Treat-to-target gout therapy that lowers serum urate is linked to reduced heart attack and stroke risk in people with gout, ...

For people trapped in the cycle of severe depression, hope is a cruel tease. It arrives briefly with a new pill or a round of ...

After surgery, some older adults don't simply recover—they unravel. Confusion, inattention, and agitation can set in, a condition known as postoperative delirium. For patients already living with ...

Research shows that vagus nerve stimulation can provide long-lasting benefits for patients who do not respond to conventional treatments Around 20% of adults in the United States will experience major ...

Researchers discovered a feedback loop between nerve cells, the immune system and the heart. They think it shows promise as a ...